Breast cancer
Conditions
Interventions
experimental group :Treatment with docetaxel
Sponsors
Shi Qingping
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: From January 2019 to the present, he was admitted to the First Affiliated Hospital of Bengbu Medical College and confirmed to be breast cancer patients by clinical pathophysiology diagnosis, aged >=18 years; karnofsky performance status (KPS) >=70, expected survival Patients with >=3 months; pre-chemotherapy blood routine, liver and kidney function tests meet the following criteria: white blood cells >=3.0*10^9 / L, neutrophils >= 1.5*10^9 / L, platelets >= 80*10^9 / L, serum bile Red pigment <= 2.0 times the upper limit of normal value, serum alanine aminotransferase, aspartate aminotransferase <= 2.5 times the upper limit of normal value.
Exclusion criteria
Exclusion criteria: Patients with poor treatment compliance; patients with other important organ diseases; pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood concentration; | — |
Countries
China
Contacts
Public ContactShi Qingping
The First Affiliated Hospital of Bengbu Medical College
Outcome results
None listed